EBF Spring Focus Workshop 2023 – Scientific, Regulatory and Technology Challenges in the Development of Oligonucleotide and Peptide Drugs
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies. The goal was to create a platform for discussions around science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. Until 2010, EBF membership was limited to pharmaceutical research and development companies with bioanalytical activities in Europe. From 2011 onwards, the EBF welcomed CROs involved in bioanalytical activities in Europe.
Recipharm is proud to be speaking at this year’s workshop event.
Speaker: Matthijs Pijnappel, Research Scientist, Recipharm
Presentation title: Technical challenges in method development for qualification of oligonucleotides by LC-MS in biological samples.
Please contact us if you would like to arrange a meeting.